Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lerapharm is a pharmaceutical company based in Russia that specializes in the production and distribution of a wide range of medicinal products and healthcare supplies. The company's portfolio primarily includes generic medications, antiseptics, and over-the-counter (OTC) products such as chlorhexidine and various topical treatments. Lerapharm operates manufacturing facilities that comply with regional standards to supply the domestic market with essential medicines. In addition to manufacturing, the company acts as a wholesaler and distributor, ensuring the availability of pharmaceutical goods across various regions in Russia. Their business model focuses on providing affordable healthcare solutions through a robust supply chain and localized production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LeraPharm.